Feedback / Questions
Prevymis (letermovir) - Merck (MSD)
https://eacs2025.abstractserver.com/program/#/details/presentations/637
J. Koethe 1; C. Wanjalla 1; D. Kitch 2; S. Qiu 2; D. Smith 3; M. Freeman 4; S. Gianella 3; P. Hunt 5; for the ACTG 5383 (ELICIT) Trial Team
Jul 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next